510(k) K183223

Simplexa Bordetella Direct, Simplexa Bordetella Positive Control Pack by Diasorin Molecular, LLC — Product Code OZZ

K183223 is an FDA 510(k) premarket notification submitted by Diasorin Molecular, LLC for the device "Simplexa Bordetella Direct, Simplexa Bordetella Positive Control Pack". The FDA issued a decision of Substantially Equivalent on Dec 19, 2018. The device falls under product code OZZ (Bordetella Pertussis Dna Assay System), a Class II device regulated under 21 CFR 866.3980. Diasorin Molecular, LLC has 13 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 19, 2018
Date Received
Nov 20, 2018
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Bordetella Pertussis Dna Assay System
Device Class
Class II
Regulation Number
866.3980
Review Panel
MI
Submission Type
510(k)

A qualitative in vitro diagnostic assay intended to detect Bordetella pertussis DNA extracted from human respiratory specimens. Detection of Bordetella pertussis DNA aids in the diagnosis of Bordetella pertussis respiratory infection in conjunction with other clinical and laboratory testing in patients exhibiting signs and symptoms of upper respiratory tract infection.

Need the full FDA record for Diasorin Molecular, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K183223. Report a data issue: hello@regdatalab.com.